Malignancy, cancer, carcinoma, colon carcinoma, colon cancer, metastasis Cancer, colon cancer, metastasis
Conditions
Interventions
Sponsors
OLVG
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria are based on an internal retrospective analysis of characteristics of patients with early discharges (1 day) after minimal invasive colon surgery [internal analysis, unpublished data] combined with the experience gained with the bariatric SDD protocol. In order to be eligible to participate in this study, a subject must meet all of the following surgical and patient specific criteria:1. Anticipated colonic resection (ileocecal, right/left hemicolectomy, transverse colectomy, sigmoid resection, colostomy reversal) without stoma2. Procedure not combined with additional resections 3. No usage of anticoagulants 4. ASA classification 1 or 26. Patient is able to use an ear thermometer and a pulse-oxymeter7. Patient has an informal caregiver (e.g. partner, family member, friend) present for the first 24 hours after surgery. 8. Patient resides within a 45 minutes’ drive from the OLVG Hospital
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study:1. Patients younger than 18 years old2. Patient does not wish to undergo SDD3. History of postoperative nausea and vomitingSecondary exclusion criteria are determined postoperatively and are the following: 1. Either surgical or anesthesiological complications hindering SDD 2. Abnormal vital signs (tachycardia >100, temperature above 38.4 Celsius, hypotension at the end of the afternoon) or drop in Haemoglobin level >1 point 6 hours postoperatively3. Postoperative vomiting, wound problems, excess pain, or other causes of doubt.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In this present study the primary outcome is the percentage of successful SDD with usage of remote monitoring. Successful SDD was defined as SDD without readmission within 48 hours. This endpoint is chosen to assess the feasibility of the concept in current practice. SDD is considered feasible if >75% successful SDD can be applied in the selected patient group. | — |
Secondary
| Measure | Time frame |
|---|---|
| To obtain information about the safety of SDD and remote monitoring of the selected group of patients undergoing hepatic surgery we will analyse adverse outcomes including complications ranked in the Clavien-Dindo classification, emergency room presentations, readmissions, reoperations and mortality. Furthermore, monitoring of time to detection of the complication and prompt treatment is necessary as these factors contribute to the patient’s outcome. We will evaluate patient satisfaction and experience with the hospital care around SDD by using the QoR-15 Patient Survey. The questionnaire will be given to patients after the operation, this composed questionnaire consisting of two sections, involving 10-point Likert scale questions. The QoR-15 Patient survey is a validated and efficient measurement of postoperative recovery. | — |
Countries
Netherlands
Contacts
Public ContactB.W. Verboeket
OLVG
Outcome results
None listed